Literature DB >> 1575592

Immunoadsorbent plasmapheresis for a patient with antiphospholipid syndrome during pregnancy.

S Kobayashi1, N Tamura, H Tsuda, C Mokuno, H Hashimoto, S Hirose.   

Abstract

The case of a 34 year old woman with systemic lupus erythematosus with a history of three previous recurrent abortions and lupus anticoagulant and anticardiolipin antibodies is reported. Immunoadsorbent plasmapheresis with a dextran sulphate column was used to remove lupus anticoagulant, anticardiolipin antibodies, and antibodies to DNA during her fourth pregnancy in combination with low doses of aspirin and prednisolone. Although during the course of treatment prednisolone was transiently increased to 30 mg/day owing to an asymptomatic increase of lupus anticoagulant and anticardiolipin antibodies, the levels of lupus anticoagulant, anticardiolipin antibodies, and antibodies to DNA were decreased by immunoadsorbent plasmapheresis and a baby girl was delivered successfully by caesarean section. Therefore, immunoadsorbent plasmapheresis with dextran sulphate seems to reduce the risk of recurrent abortion in patients with the antiphospholipid syndrome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1575592      PMCID: PMC1004672          DOI: 10.1136/ard.51.3.399

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  15 in total

1.  Inhibitory effect of a new synthetic protease inhibitor (FUT-175) on the coagulation system.

Authors:  Y Hitomi; N Ikari; S Fujii
Journal:  Haemostasis       Date:  1985

2.  Complete congenital heart block: risk of occurrence and therapeutic approach to prevention.

Authors:  J Buyon; R Roubey; S Swersky; L Pompeo; A Parke; L Baxi; R Winchester
Journal:  J Rheumatol       Date:  1988-07       Impact factor: 4.666

3.  Comparative evaluation of a partial thromboplastin reagent containing a non-settling, particulate activator.

Authors:  A L Babson; S R Babson
Journal:  Am J Clin Pathol       Date:  1974-12       Impact factor: 2.493

4.  A novel system of LDL apheresis combining a centrifugal plasma separator with a specific LDL adsorption column.

Authors:  T Nakajima; T Nakamura; T Funahashi; H Kanai; Y Kurata; Y Matsuzawa; S Tarui
Journal:  Atherosclerosis       Date:  1988-10       Impact factor: 5.162

5.  Selective removal of anti-double-stranded DNA antibodies by immunoadsorption with dextran sulphate in a patient with systemic lupus erythematosus.

Authors:  M Kinoshita; S Aotsuka; T Funahashi; N Tani; R Yokohari
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

6.  Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986.

Authors:  E N Harris; A E Gharavi; S P Patel; G R Hughes
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

7.  Fetal survival after prednisone suppression of maternal lupus-anticoagulant.

Authors:  W F Lubbe; W S Butler; S J Palmer; G C Liggins
Journal:  Lancet       Date:  1983-06-18       Impact factor: 79.321

8.  Extracorporeal hydrophobic amino acid adsorbent therapy in rheumatoid arthritis.

Authors:  K Takahashi; S Yoshinoya; H Yoshizawa; T Miyamoto
Journal:  Clin Rheumatol       Date:  1987-12       Impact factor: 2.980

9.  Obstetric complications associated with the lupus anticoagulant.

Authors:  D W Branch; J R Scott; N K Kochenour; E Hershgold
Journal:  N Engl J Med       Date:  1985-11-21       Impact factor: 91.245

Review 10.  Lupus anticoagulant and pregnancy.

Authors:  W F Lubbe; G C Liggins
Journal:  Am J Obstet Gynecol       Date:  1985-10-01       Impact factor: 8.661

View more
  8 in total

1.  Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.

Authors:  Karoline Mayer-Pickel; Katharina Eberhard; Uwe Lang; Mila Cervar-Zivkovic
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

Review 2.  Treatment of the antiphospholipid syndrome.

Authors:  J C Piette; M Karmochkine; T Papo; L T Du; C Francès; B Wechsler
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

3.  False negative results of anticardiolipin antibody test.

Authors:  S Kobayashi; M Tanaka; H Tsuda; H Hashimoto; S Hirose; T Saikawa; K Yoshida
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

Review 4.  Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant.

Authors:  M Empson; M Lassere; J Craig; J Scott
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

5.  What's new in obstetric antiphospholipid syndrome.

Authors:  D Ware Branch
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 6.  Treatment options for juvenile-onset systemic lupus erythematosus.

Authors:  Luis Carreño; Francisco Javier López-Longo; Carlos Manuel González; Indalecio Monteagudo
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 7.  Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review.

Authors:  Amelia Ruffatti; Ariela Hoxha; Maria Favaro; Marta Tonello; Anna Colpo; Umberto Cucchini; Alessandra Banzato; Vittorio Pengo
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

8.  Response to Plasmapheresis Measured by Angiogenic Factors in a Woman with Antiphospholipid Syndrome in Pregnancy.

Authors:  Karoline Mayer-Pickel; Sabine Horn; Uwe Lang; Mila Cervar-Zivkovic
Journal:  Case Rep Obstet Gynecol       Date:  2015-08-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.